capriCORN

Comprehensive Analysis of Pathogens, Resistomes, and Inflammatory-markers in the CORNea

About the Study

Infectious corneal ulcers affect all ages and contribute to significant visual morbidity worldwide. Empiric treatment with broad spectrum antimicrobials without regard for antimicrobial resistance is presently standard of care. This is either because pathogen identification with routine microbiological testing is suboptimal or testing is not done altogether. While empiric treatment is the preferred practice pattern for infectious keratitis worldwide, this is contrary to the goals and ideals of antimicrobial stewardship.

This study takes advantage of international collaborations and recent advances in genomic technologies to identify pathogens and provide regional AMR profiles to these infections. The results of this study may help to decrease AMR proliferation and improve diagnostics and therapeutic approaches for infectious keratitis, thus reducing the worldwide burden of corneal blindness.

Study Sites

World map showing 23 Capricorn study sites: 13 in the Americas, 3 in Europe, 1 in the Middle East, 2 in Africa, and 4 in Asia.

On smaller screens, swipe left across the table to see all columns of the table below.

Site ID

Site name

Site collaborators

City

Country

1

Eyesight Hawaii

Kristin Hirabayashi, MD; John Olkowski, MD

Honolulu

USA

2

Oregon Health and Science University

Travis Redd, MD, MPH

Portland

USA

3

University of California, San Francisco: Francis I Proctor Foundation

See Study Team

San Francisco

USA

4

University of California, Los Angeles: Stein Eye Center

Simon Fung, MD, MA

Los Angeles

USA

5

University of California, San Diego: Shiley Eye Institute

Esmeralda McClean, OD

San Diego

USA

6

Moran Eye Center, University of Utah

Amy Lin, MD

Salt Lake City

USA

7

Cornea Associates of Texas

Josh Zaffos, MD

Dallas

USA

8

Washington University in St. Louis

Praneetha Thulasi, MD

St. Louis

USA

9

University of Wisconsin School of Medicine and Public Health

Sarah Nehls, MD

Madison

USA

10

Price Vision Group

Francis Price, MD; Marianne Price, PhD

Indianapolis

USA

11

Harkness Eye Institute, Columbia University

Leejee Suh, MD

New York

USA

12

Instituto Mexicano de Oftalmología

Charles Van Lansingh, MD, PhD; Jose Fernando Perez, MD; Ellery Lopez, MD

Santiago de Querétaro

Mexico

13

Visualiza Sociedad Anonima

Mario Renato Papa, MD

Guatemala City

Guatemala

14

Maastricht University Medical Center

Mor M. Dickman, MD, PhD

Maastricht

Netherlands

15

Universitätsklinikum des Saarlandes

Berthold Seitz, MD; Tim Berger, MD; Loic Hamon, MD

Homburg

Germany

16

Pallas Kliniken

Prof. Dr. Christoph Tappeiner; Prof. Dr. David Goldblum

Olten

Switzerland

17

Rabin Medical Center

Ruti Sella, MD; Lee Terner, MD

Petah Tikva

Israel

18

Niger Ministry of Health, Programme National de Santé Oculaire

Abdou Amza, MD, PhD

Niamey

Niger

19

Blantyre Institute for Community Outreach

Khumbo Kalua, MD, PhD

Blantyre

Malawi

20

Chulalongkorn University

Vannarut Satipitakul, MD

Bangkok

Thailand

21

Phramongkutklao Hospital

Wiwan Sansanayudh, MD

Bangkok

Thailand

22

Singapore National Eye Center

Jod Mehta, MD, PhD; Yu Chi Liu, MD

Singapore

Singapore

23

Taipei Veterans General Hospital, Taipei, Taiwan

Nai-Wen Fan, MD

Taipei

Taiwan-Republic of China

 

Study Team

Contact

Email: [email protected]